Compass Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$53.8K Buy
103
+1
+1% +$512 0.01% 721
2026
Q2
$48.9K Buy
+102
New +$45.2K 0.01% 698

Other funds holding VRTX

Compass Financial Management's VRTX Position: Q3 2026 in Review

Compass Financial Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.98% in Q3 2026, buying an estimated $512 and bringing the position to 103 shares worth $53.8K. The position accounts for 0.01% of the portfolio, ranked #721.

Compass Financial Management first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Compass Financial Management held 103 shares of Vertex Pharmaceuticals worth $53.8K as of Q3 2026.
  • Compass Financial Management bought 1 Vertex Pharmaceuticals share in Q3 2026, an estimated $512.
  • Vertex Pharmaceuticals made up 0.01% of Compass Financial Management's portfolio in Q3 2026, its #721 holding.
  • Compass Financial Management first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.